nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentolinium—CHRNB4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Parkinson's disease	0.0567	0.0591	CbGpPWpGaD
Pentolinium—CHRNA3—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Parkinson's disease	0.0519	0.0541	CbGpPWpGaD
Pentolinium—CHRNA3—Nicotine Activity on Dopaminergic Neurons—PPP1R1B—Parkinson's disease	0.0469	0.0489	CbGpPWpGaD
Pentolinium—CHRNB4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0464	0.0483	CbGpPWpGaD
Pentolinium—CHRNA3—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0424	0.0442	CbGpPWpGaD
Pentolinium—CHRNB4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0395	0.0412	CbGpPWpGaD
Pentolinium—CHRNB4—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0368	0.0384	CbGpPWpGaD
Pentolinium—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0361	0.0377	CbGpPWpGaD
Pentolinium—CHRNA3—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0337	0.0351	CbGpPWpGaD
Pentolinium—CHRNB4—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0326	0.0339	CbGpPWpGaD
Pentolinium—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DDC—Parkinson's disease	0.032	0.0334	CbGpPWpGaD
Pentolinium—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0298	0.0311	CbGpPWpGaD
Pentolinium—CHRNA3—Nicotine Activity on Dopaminergic Neurons—SLC18A2—Parkinson's disease	0.0272	0.0284	CbGpPWpGaD
Pentolinium—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—Parkinson's disease	0.0215	0.0224	CbGpPWpGaD
Pentolinium—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD3—Parkinson's disease	0.0194	0.0202	CbGpPWpGaD
Pentolinium—CHRNA3—Nicotine Activity on Dopaminergic Neurons—TH—Parkinson's disease	0.0178	0.0186	CbGpPWpGaD
Pentolinium—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—Parkinson's disease	0.0175	0.0183	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.0149	0.0155	CbGpPWpGaD
Pentolinium—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.0117	0.0122	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.0113	0.0118	CbGpPWpGaD
Pentolinium—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.0107	0.0112	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—HCN3—Parkinson's disease	0.0105	0.0109	CbGpPWpGaD
Pentolinium—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.0101	0.0106	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—HCN3—Parkinson's disease	0.00959	0.00999	CbGpPWpGaD
Pentolinium—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00926	0.00965	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00881	0.00919	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00806	0.0084	CbGpPWpGaD
Pentolinium—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00792	0.00826	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00761	0.00793	CbGpPWpGaD
Pentolinium—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00724	0.00755	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00703	0.00733	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00696	0.00725	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—KCNJ4—Parkinson's disease	0.00675	0.00704	CbGpPWpGaD
Pentolinium—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00673	0.00702	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—KCNJ4—Parkinson's disease	0.00618	0.00644	CbGpPWpGaD
Pentolinium—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00616	0.00642	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00595	0.00621	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—DLG1—Parkinson's disease	0.00583	0.00608	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00545	0.00568	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—DLG1—Parkinson's disease	0.00533	0.00556	CbGpPWpGaD
Pentolinium—CHRNA3—forebrain—Parkinson's disease	0.00527	0.129	CbGeAlD
Pentolinium—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00516	0.00538	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00506	0.00528	CbGpPWpGaD
Pentolinium—CHRNB4—head—Parkinson's disease	0.00492	0.121	CbGeAlD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.0049	0.00511	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00473	0.00493	CbGpPWpGaD
Pentolinium—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00472	0.00492	CbGpPWpGaD
Pentolinium—CHRNB4—nervous system—Parkinson's disease	0.00466	0.114	CbGeAlD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00463	0.00483	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—GRIK1—Parkinson's disease	0.00456	0.00476	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00456	0.00475	CbGpPWpGaD
Pentolinium—CHRNB4—central nervous system—Parkinson's disease	0.00449	0.11	CbGeAlD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00449	0.00468	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00448	0.00467	CbGpPWpGaD
Pentolinium—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00444	0.00463	CbGpPWpGaD
Pentolinium—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00434	0.00452	CbGpPWpGaD
Pentolinium—CHRNA10—head—Parkinson's disease	0.00433	0.106	CbGeAlD
Pentolinium—CHRNA3—Neuronal System—GRIK1—Parkinson's disease	0.00417	0.00435	CbGpPWpGaD
Pentolinium—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00406	0.00423	CbGpPWpGaD
Pentolinium—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00397	0.00414	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00392	0.00409	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00388	0.00404	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—GRIK2—Parkinson's disease	0.00388	0.00404	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—SLC18A2—Parkinson's disease	0.00376	0.00392	CbGpPWpGaD
Pentolinium—CHRNB4—brain—Parkinson's disease	0.00356	0.0875	CbGeAlD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00356	0.00371	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00355	0.0037	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—GRIK2—Parkinson's disease	0.00355	0.0037	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—SLC18A2—Parkinson's disease	0.00344	0.00358	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00334	0.00348	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00331	0.00345	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00326	0.0034	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00325	0.00339	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00322	0.00335	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.0032	0.00333	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00305	0.00318	CbGpPWpGaD
Pentolinium—CHRNA3—head—Parkinson's disease	0.00302	0.0741	CbGeAlD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00298	0.00311	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—CHRNA4—Parkinson's disease	0.00297	0.0031	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00294	0.00307	CbGpPWpGaD
Pentolinium—CHRNA3—nervous system—Parkinson's disease	0.00286	0.0702	CbGeAlD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00284	0.00296	CbGpPWpGaD
Pentolinium—CHRNA3—central nervous system—Parkinson's disease	0.00275	0.0676	CbGeAlD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00273	0.00285	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—HSPA8—Parkinson's disease	0.00273	0.00284	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—CHRNA4—Parkinson's disease	0.00272	0.00283	CbGpPWpGaD
Pentolinium—CHRNB4—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00271	0.00283	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.0027	0.00281	CbGpPWpGaD
Pentolinium—CHRNA3—cerebellum—Parkinson's disease	0.00269	0.0661	CbGeAlD
Pentolinium—CHRNB4—Neuronal System—DLG4—Parkinson's disease	0.00256	0.00267	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.0025	0.00261	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—GRIN2B—Parkinson's disease	0.0025	0.00261	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—HSPA8—Parkinson's disease	0.00249	0.0026	CbGpPWpGaD
Pentolinium—CHRNA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00248	0.00259	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—SLC6A3—Parkinson's disease	0.00246	0.00257	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—DLG4—Parkinson's disease	0.00234	0.00244	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—GRIN2B—Parkinson's disease	0.00229	0.00238	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—SLC6A3—Parkinson's disease	0.00225	0.00235	CbGpPWpGaD
Pentolinium—CHRNA3—brain—Parkinson's disease	0.00219	0.0537	CbGeAlD
Pentolinium—CHRNB4—Neuronal System—COMT—Parkinson's disease	0.00209	0.00218	CbGpPWpGaD
Pentolinium—CHRNB4—Neuronal System—MAOA—Parkinson's disease	0.00208	0.00217	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—COMT—Parkinson's disease	0.00192	0.002	CbGpPWpGaD
Pentolinium—CHRNA3—Neuronal System—MAOA—Parkinson's disease	0.0019	0.00198	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.0016	0.00167	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.0016	0.00166	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00116	0.00121	CbGpPWpGaD
Pentolinium—CHRNB4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000937	0.000977	CbGpPWpGaD
